JSRP1: A Potential Drug Target and Biomarker (G126306)

Target Name: JSRP1

NCBI ID: G126306

JSRP1: A Potential Drug Target and Biomarker

JSRP1, also known as junctional-face membrane protein of 45 kDa homolog, is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the Junctional Transmembrane Protein (JTBP) family , which is known for their involvement in various physiological processes, including cell signaling and tissue structure. The JSRP1 protein has been identified as a potential drug target and biomarker, due to its unique structure and subcellular localization.

Structure and Localization

The JSRP1 protein is a 45 kDa protein that consists of 155 amino acid residues. It has a unique structure, with a cytoplasmic tail that is rich in electrolytes, such as sodium, potassium, and magnesium. This tail is also involved in JSRP1's localization to the plasma membrane, where it functions as a receptor for various signaling molecules.

JSRP1 is expressed in a variety of tissues and cells in the body, including the brain, where it is highly expressed in the hippocampus, a region of the brain that is involved in memory and learning. It is also expressed in the heart and lungs, where it is involved in cardiac function and gas exchange, respectively.

Function and Localization

The JSRP1 protein is involved in various physiological processes in the body, including cell signaling, neurotransmitter release, and tissue structure. Its function is closely related to the regulation of ion channels in the plasma membrane, which are responsible for the flow of electrical signals across the cell membrane.

JSRP1 functions as a receptor for various signaling molecules, including neurotransmitters such as dopamine and nitric oxide. These molecules are involved in various cellular processes, including neurotransmission, synaptic plasticity, and cardiovascular function.

In addition to its role in signaling, JSRP1 is also involved in the regulation of cell shape and the maintenance of tissue structure. Its cytoplasmic tail is rich in electrolytes, which is important for maintaining the stability of the plasma membrane and the integrity of the cell.

Drug Targeting

JSRP1's unique structure and subcellular localization make it an attractive drug target. Studies have shown that JSRP1 can be targeted by small molecules, including inhibitors of ion channels and neurotransmitter receptors. In addition, JSRP1 can be targeted by antibodies that recognize its unique cytoplasmic tail.

One of the most promising strategies for targeting JSRP1 is the use of small molecules that can modulate the activity of ion channels or neurotransmitter receptors that are involved in its function. For example, inhibitors of the voltage-dependent calcium channel (VDCC) have have been shown to be effective in reducing the activity of JSRP1 and its localization to the plasma membrane. Similarly, inhibitors of the neurotransmitter receptor DOPA have been shown to reduce the release of neurotransmitters from JSRP1-expressing cells.

Another approach to targeting JSRP1 is the use of antibodies that recognize its unique cytoplasmic tail. These antibodies have been shown to be effective in blocking the localization of JSRP1 to the plasma membrane and promoting its degradation in cell experiments.

Biomarker Potential

JSRP1 has been identified as a potential biomarker for various diseases, including neurodegenerative disorders, psychiatric disorders, and cardiovascular disease. Its unique structure and subcellular localization make it an attractive target for diagnostic tools and therapies.

For example, JSRP1 has been shown to be highly expressed in the brains of individuals with Alzheimer's disease, a neurodegenerative disorder that is characterized by the progressive loss of brain cells. In addition, JSRP1 has been shown to be involved in

Protein Name: Junctional Sarcoplasmic Reticulum Protein 1

Functions: Involved in skeletal muscle excitation/contraction coupling (EC), probably acting as a regulator of the voltage-sensitive calcium channel CACNA1S. EC is a physiological process whereby an electrical signal (depolarization of the plasma membrane) is converted into a chemical signal, a calcium gradient, by the opening of ryanodine receptor calcium release channels. May regulate CACNA1S membrane targeting and activity

More Common Targets